On May 20, 2025, the Reporting Persons, Brett Icahn and Steven Miller (collectively, the "Icahn Group") entered into a Supplemental Letter Agreement (the "Supplemental Letter Agreement") with the Issuer. Pursuant to the Supplemental Letter Agreement, the Icahn Group has agreed that if it engages in a Specified Action (as such term is defined in the Supplemental Letter Agreement), then (i) its designees serving on the board of directors of the Issuer (the "BHC Board") shall immediately tender their resignations from the BHC Board and from the board of directors of Bausch + Lomb Corporation (the "B+L Board"), and (ii) it shall irrevocably waive its rights under specified provisions of the Amended and Restated Director Appointment and Nomination Agreement, dated June 21, 2022, between Bausch + Lomb Corporation and certain members of the Icahn Group (the "B+L DANA"), including the right to designate any Replacement Designees (as such term is defined in the B+L DANA). In addition, pursuant to the Supplemental Letter Agreement, so long as no member of the Icahn Group has engaged in a Specified Action, the Issuer has agreed (i) if such person or member of the Icahn Group (each, an "Icahn Group Designee") is named as a management nominee for election to the B+L Board at any meeting of shareholders of Bausch + Lomb Corporation, then the Issuer shall vote or cause to be voted all voting securities of Bausch + Lomb Corporation owned or controlled by the Issuer for each such Icahn Group Designee, and (ii) such Icahn Group Designee will also have the right to be appointed to any newly-created committees of the BHC Board, absent actual conflicts of interest. The foregoing description of the Supplemental Letter Agreement is qualified in its entirety by reference to the full text of the Supplemental Letter Agreement, a copy of which is incorporated by reference herein.